Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US.
Goswami, Hardik; Alsumali, Adnan; Jiang, Yiling; Schindler, Matthias; Duke, Elizabeth R; Cohen, Joshua; Briggs, Andrew; Puenpatom, Amy.
Afiliação
  • Goswami H; BARDS-Health Economics and Decision Science, Merck & Co, Inc., Kenilworth, NJ, USA. hardik.goswami@merck.com.
  • Alsumali A; BARDS-Health Economics and Decision Science, Merck & Co, Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA. hardik.goswami@merck.com.
  • Jiang Y; BARDS-Health Economics and Decision Science, Merck & Co, Inc., Kenilworth, NJ, USA.
  • Schindler M; BARDS-Health Economics and Decision Science MSD (UK) Ltd, London, UK.
  • Duke ER; BARDS-HTA, MSD Ltd, Zurich, Switzerland.
  • Cohen J; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Briggs A; Center for the Evaluation of Value and Risk in Health, Boston, MA, USA.
  • Puenpatom A; London School of Hygiene and Tropical Medicine, London, UK.
Pharmacoeconomics ; 40(7): 699-714, 2022 07.
Article em En | MEDLINE | ID: mdl-35779197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / COVID-19 Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pacientes Ambulatoriais / COVID-19 Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article